{"id":"W4405375041","doi":"10.1016/j.iotech.2024.100746","title":"117O Stereotactic body radiotherapy (SBRT) with pembrolizumab (pembro) for unresected stage I/II non-small cell lung cancer (NSCLC): The randomized, double-blind, phase III KEYNOTE-867 study","year":2024,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Pembrolizumab; Medicine; Lung cancer; Stage (stratigraphy); Oncology; Medical physics; Internal medicine; Cancer; Immunotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009073637,0.0007982142,0.002196153,0.0008850752,0.0005945308,0.0001022652,0.0006845262,0.0007238592,0.0004229599],"category_scores_gemma":[0.00005175178,0.0004772136,0.0004440816,0.001258321,0.0007793105,0.0001441175,0.0002223308,0.001114964,0.00001466066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002452344,"about_ca_system_score_gemma":0.001979605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001120146,"about_ca_topic_score_gemma":0.001005899,"domain_scores_codex":[0.9959817,0.000269329,0.001037048,0.001250365,0.000360953,0.001100594],"domain_scores_gemma":[0.9963273,0.001253782,0.0004380088,0.001467134,0.0003658278,0.0001479165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9305453,0.01022023,0.005467124,0.0007511221,0.01578308,0.00162709,0.005812145,0.00005234269,0.008318468,0.001101473,0.005463334,0.01485834],"study_design_scores_gemma":[0.9280694,0.01757894,0.000188566,0.000425388,0.005942056,0.0003926281,0.001689438,0.002248736,0.009560136,0.000062017,0.03324534,0.0005973654],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9250619,0.04066495,0.001881964,0.01076169,0.001436719,0.01845328,0.00007131457,0.0007497063,0.0009184049],"genre_scores_gemma":[0.9683782,0.003934121,0.00046155,0.0005331371,0.0003274337,0.02219075,0.00007013683,0.0001960381,0.003908657],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0433162,"threshold_uncertainty_score":0.999768,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0171213817156222,"score_gpt":0.3587965159867576,"score_spread":0.3416751342711354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}